ID

14118

Descripción

Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management; ODM derived from: https://clinicaltrials.gov/show/NCT01908075

Link

https://clinicaltrials.gov/show/NCT01908075

Palabras clave

Versiones (1)
  1. 30/3/16 30/3/16 -
Subido en

30 de marzo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Asthma NCT01908075

Inglés

Eligibility Asthma NCT01908075

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT01908075
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
aged: 18-80 years 61-80 years to be non-smokers only
Descripción

Age | Non-smoker

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0337672
evidence of asthma: a diagnostic code for asthma or two scripts for asthma..
Descripción

Asthma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004096
baseline fp/sal therapy: ≥2 prescription for ics/laba therapy as fp/sal
Descripción

fluticasone | salmeterol | Therapeutic procedure | inhaled steroids | Adrenergic beta-2 Receptor Agonists | Therapeutic procedure

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0082607
UMLS CUI [1,2]
C0073992
UMLS CUI [1,3]
C0087111
UMLS CUI [2,1]
C2065041
UMLS CUI [2,2]
C2936789
UMLS CUI [2,3]
C0087111
evidence of continuing therapy: include only patients who receive ≥2 prescriptions for the therapy under study during the outcome year (i.e. ≥1 prescription at the index date and ≥1 other). uk average is 3-4 prescriptions refilled per year, so ≥2 ensures capture of "real-life" data.
Descripción

Continuous therapeutic procedure | prescription

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0549178
UMLS CUI [2]
C1521941
evidence of switching for economic reasons: fp/sal patients from practices with ≥5 switches to fostair in a 3 month period to minimise data taken from switching of anomalous patients; optimal practices for inclusion are those switching "wholesale" for economic reasons.
Descripción

Therapy change | fluticasone salmeterol

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3665894
UMLS CUI [2,1]
C0082607
UMLS CUI [2,2]
C0073992
UMLS CUI [2,3]
C0087111
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
any chronic respiratory disease other than asthma
Descripción

Chronic disease of respiratory system

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0264220
UMLS CUI [2]
C0004096
are receiving maintenance oral steroid therapy during baseline period
Descripción

Oral steroid therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0087111
Volver a la parte superior de la página

Similar models

Eligibility Asthma NCT01908075

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT01908075
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age | Non-smoker
Item
aged: 18-80 years 61-80 years to be non-smokers only
boolean
C0001779 (UMLS CUI [1])
C0337672 (UMLS CUI [2])
Asthma
Item
evidence of asthma: a diagnostic code for asthma or two scripts for asthma..
boolean
C0004096 (UMLS CUI [1])
fluticasone | salmeterol | Therapeutic procedure | inhaled steroids | Adrenergic beta-2 Receptor Agonists | Therapeutic procedure
Item
baseline fp/sal therapy: ≥2 prescription for ics/laba therapy as fp/sal
boolean
C0082607 (UMLS CUI [1,1])
C0073992 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C2065041 (UMLS CUI [2,1])
C2936789 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
Continuous therapeutic procedure | prescription
Item
evidence of continuing therapy: include only patients who receive ≥2 prescriptions for the therapy under study during the outcome year (i.e. ≥1 prescription at the index date and ≥1 other). uk average is 3-4 prescriptions refilled per year, so ≥2 ensures capture of "real-life" data.
boolean
C0087111 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
C1521941 (UMLS CUI [2])
Therapy change | fluticasone salmeterol
Item
evidence of switching for economic reasons: fp/sal patients from practices with ≥5 switches to fostair in a 3 month period to minimise data taken from switching of anomalous patients; optimal practices for inclusion are those switching "wholesale" for economic reasons.
boolean
C3665894 (UMLS CUI [1])
C0082607 (UMLS CUI [2,1])
C0073992 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Chronic disease of respiratory system
Item
any chronic respiratory disease other than asthma
boolean
C0264220 (UMLS CUI [1])
C0004096 (UMLS CUI [2])
Oral steroid therapy
Item
are receiving maintenance oral steroid therapy during baseline period
boolean
C0001617 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial